Original Research and the Latest News

How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%

by Webtyde | October 16, 2025 | New Technology, Probability of Success | 0 Comments

Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success (POS) forecasting can revolutionize the landscape of clinical trials. By adopting next-gen POS forecasting models, companies can...

Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

by Webtyde | October 13, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success | 0 Comments

The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength.Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...

Not Your Grandparents’ Probability of Success Forecasts

by Webtyde | October 9, 2025 | New Technology, Probability of Success | 0 Comments

Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and analytics, traditional Probability of Success (POS) forecasts are a familiar, yet often frustrating approach to assessing clinical risk. While...

Clinical Trial Success Rates: What Makes Some Companies Stand Out?

by Webtyde | October 9, 2025 | New Technology, Probability of Success | 0 Comments

Our comprehensive analysis of over 30,000 clinical trials across more than 4,000 biopharmaceutical companies reveals significant variations in clinical trial success rates. This disparity exists even among trials in the same phase and targeting the same disease,...

Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April

Sep 22, 2025 | Industry Trends, New Technology

The Annual Meeting of the American Association for Cancer Research (AACR) is taking place April 5-10 in San Diego. AACR...

Next Entries »

Recent Tweets

Ozmosi Follow

BioPharma/Biotech Intel. Daily $XBI $XPH Market Movers Database: https://t.co/IBOqbSoYuc Clinical trial tools: https://t.co/A77u9Q84Dc https://t.co/AQERg9nHrb

Ozmosi @ozmosihealth ·

8 Oct

$NBIX Neurocrine presented Phase 3 Huntington Disease results on 2025-10-06 for Valbenazine

More Info: https://pryzm.ozmosi.com/product/2327

Reply on Twitter 1975742106305012079 Retweet on Twitter 1975742106305012079 Like on Twitter 1975742106305012079 Twitter 1975742106305012079

Ozmosi @ozmosihealth ·

8 Oct

$KALV KalVista presented Phase 3 Angioedemas, Hereditary results on 2025-10-02 for Sebetralstat

More Info: https://pryzm.ozmosi.com/product/23056

Reply on Twitter 1975742103259955630 Retweet on Twitter 1975742103259955630 Like on Twitter 1975742103259955630 Twitter 1975742103259955630

Ozmosi @ozmosihealth ·

8 Oct

$BMEA Biomea Fusion presented Phase 2 Type 2 Diabetes results on 2025-10-06 for Icovamenib

More Info: https://pryzm.ozmosi.com/product/23569

Reply on Twitter 1975742097073328629 Retweet on Twitter 1975742097073328629 Like on Twitter 1975742097073328629 Twitter 1975742097073328629

Ozmosi @ozmosihealth ·

8 Oct

$GANX GAIN Therapeutics presented Phase 1 Parkinson's Disease results on 2025-10-06 for GT-02287

More Info: https://pryzm.ozmosi.com/product/23956

Reply on Twitter 1975742100139335988 Retweet on Twitter 1975742100139335988 Like on Twitter 1975742100139335988 Twitter 1975742100139335988

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

Get in Touch

info@ozmosi.com
(732) 701-7807

600 Warren Ave,
Spring Lake, NJ 07762

Original Research and the Latest News

How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%

Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

Not Your Grandparents’ Probability of Success Forecasts

Clinical Trial Success Rates: What Makes Some Companies Stand Out?

Recent Posts

Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April

Recent Tweets

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.